Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Criteo S.A.CRTO · Entity 291 | Director | July 29, 2026 | July 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Criteo S.A.
Report date July 29, 2026 · Filed July 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-29 · Disposition to issuer · Disposed 33,846 · Balance 0 F1: Prior to the completion of the Conversion (as defined below), the Ordinary Shares may have been represented by American Depositary Shares ("ADSs"), each of which represents one Ordinary Share and were mandatorily exchanged for one Ordinary Share per each ADS in connection with the Conversion. F2: On July 29, 2026, as previously approved by the Issuer's shareholders, the Issuer completed its conversion (the "Conversion") from a French public limited liability company ("French Criteo") to a Luxembourg public limited liability company ("Lux Criteo"). Upon the Conversion, (i) each Ordinary Share of French Criteo, including shares represented by ADSs, continued as one Ordinary Share of Lux Criteo, (ii) each time-based restricted stock unit and performance-based restricted stock unit of French Criteo continued as a time-based restricted stock unit and performance-based restricted stock unit, respectively, of Lux Criteo and (iii) each option or warrant to obtain shares of French Criteo continued as an option or warrant to obtain an equal number of shares of Lux Criteo, respectively. All rights attached to such awards remain unchanged after the Conversion, except the right to receive shares of French Criteo under these instruments became the right to receive shares of Lux Criteo. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 33,846 |
Reported balance
After 2026-07-29 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-07-29 · Grant · Acquired 33,846 · Balance 33,846 F2: On July 29, 2026, as previously approved by the Issuer's shareholders, the Issuer completed its conversion (the "Conversion") from a French public limited liability company ("French Criteo") to a Luxembourg public limited liability company ("Lux Criteo"). Upon the Conversion, (i) each Ordinary Share of French Criteo, including shares represented by ADSs, continued as one Ordinary Share of Lux Criteo, (ii) each time-based restricted stock unit and performance-based restricted stock unit of French Criteo continued as a time-based restricted stock unit and performance-based restricted stock unit, respectively, of Lux Criteo and (iii) each option or warrant to obtain shares of French Criteo continued as an option or warrant to obtain an equal number of shares of Lux Criteo, respectively. All rights attached to such awards remain unchanged after the Conversion, except the right to receive shares of French Criteo under these instruments became the right to receive shares of Lux Criteo. F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
Filing footnotes · ownership attribution and instrument terms
F1: Prior to the completion of the Conversion (as defined below), the Ordinary Shares may have been represented by American Depositary Shares ("ADSs"), each of which represents one Ordinary Share and were mandatorily exchanged for one Ordinary Share per each ADS in connection with the Conversion.
F2: On July 29, 2026, as previously approved by the Issuer's shareholders, the Issuer completed its conversion (the "Conversion") from a French public limited liability company ("French Criteo") to a Luxembourg public limited liability company ("Lux Criteo"). Upon the Conversion, (i) each Ordinary Share of French Criteo, including shares represented by ADSs, continued as one Ordinary Share of Lux Criteo, (ii) each time-based restricted stock unit and performance-based restricted stock unit of French Criteo continued as a time-based restricted stock unit and performance-based restricted stock unit, respectively, of Lux Criteo and (iii) each option or warrant to obtain shares of French Criteo continued as an option or warrant to obtain an equal number of shares of Lux Criteo, respectively. All rights attached to such awards remain unchanged after the Conversion, except the right to receive shares of French Criteo under these instruments became the right to receive shares of Lux Criteo.
F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2026 Filed Jul 29, 2026 20:02 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 33,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-050585 · wk-form4_1785355328.xml · nonDerivative · entry 2 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,846 F2 · kind: On July 29, 2026, as previously approved by the Issuer's shareholders, the Issuer completed its conversion (the "Conversion") from a French public limited liability company ("French Criteo") to a Luxembourg public limited liability company ("Lux Criteo"). Upon the Conversion, (i) each Ordinary Share of French Criteo, including shares represented by ADSs, continued as one Ordinary Share of Lux Criteo, (ii) each time-based restricted stock unit and performance-based restricted stock unit of French Criteo continued as a time-based restricted stock unit and performance-based restricted stock unit, respectively, of Lux Criteo and (iii) each option or warrant to obtain shares of French Criteo continued as an option or warrant to obtain an equal number of shares of Lux Criteo, respectively. All rights attached to such awards remain unchanged after the Conversion, except the right to receive shares of French Criteo under these instruments became the right to receive shares of Lux Criteo. F2 · price: On July 29, 2026, as previously approved by the Issuer's shareholders, the Issuer completed its conversion (the "Conversion") from a French public limited liability company ("French Criteo") to a Luxembourg public limited liability company ("Lux Criteo"). Upon the Conversion, (i) each Ordinary Share of French Criteo, including shares represented by ADSs, continued as one Ordinary Share of Lux Criteo, (ii) each time-based restricted stock unit and performance-based restricted stock unit of French Criteo continued as a time-based restricted stock unit and performance-based restricted stock unit, respectively, of Lux Criteo and (iii) each option or warrant to obtain shares of French Criteo continued as an option or warrant to obtain an equal number of shares of Lux Criteo, respectively. All rights attached to such awards remain unchanged after the Conversion, except the right to receive shares of French Criteo under these instruments became the right to receive shares of Lux Criteo. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| July 29, 2026 Filed Jul 29, 2026 20:02 UTC | Criteo S.A. CRTO · Entity 291 | Disposition to issuerOrdinary Shares | 33,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-050585 · wk-form4_1785355328.xml · nonDerivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Prior to the completion of the Conversion (as defined below), the Ordinary Shares may have been represented by American Depositary Shares ("ADSs"), each of which represents one Ordinary Share and were mandatorily exchanged for one Ordinary Share per each ADS in connection with the Conversion. F2 · kind: On July 29, 2026, as previously approved by the Issuer's shareholders, the Issuer completed its conversion (the "Conversion") from a French public limited liability company ("French Criteo") to a Luxembourg public limited liability company ("Lux Criteo"). Upon the Conversion, (i) each Ordinary Share of French Criteo, including shares represented by ADSs, continued as one Ordinary Share of Lux Criteo, (ii) each time-based restricted stock unit and performance-based restricted stock unit of French Criteo continued as a time-based restricted stock unit and performance-based restricted stock unit, respectively, of Lux Criteo and (iii) each option or warrant to obtain shares of French Criteo continued as an option or warrant to obtain an equal number of shares of Lux Criteo, respectively. All rights attached to such awards remain unchanged after the Conversion, except the right to receive shares of French Criteo under these instruments became the right to receive shares of Lux Criteo. F2 · price: On July 29, 2026, as previously approved by the Issuer's shareholders, the Issuer completed its conversion (the "Conversion") from a French public limited liability company ("French Criteo") to a Luxembourg public limited liability company ("Lux Criteo"). Upon the Conversion, (i) each Ordinary Share of French Criteo, including shares represented by ADSs, continued as one Ordinary Share of Lux Criteo, (ii) each time-based restricted stock unit and performance-based restricted stock unit of French Criteo continued as a time-based restricted stock unit and performance-based restricted stock unit, respectively, of Lux Criteo and (iii) each option or warrant to obtain shares of French Criteo continued as an option or warrant to obtain an equal number of shares of Lux Criteo, respectively. All rights attached to such awards remain unchanged after the Conversion, except the right to receive shares of French Criteo under these instruments became the right to receive shares of Lux Criteo. Read SEC document |
| November 04, 2025 Filed Nov 5, 2025 21:27 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 6,450 | $22.61 | $145,834.50 |
DisclosureSEC source: 0001711277-25-000004 · wk-form4_1762378034.xml · nonDerivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,846 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 21:08 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 3,625 | $39.36 | $142,680.00 |
DisclosureSEC source: 0001576427-24-000142 · wk-form4_1732655327.xml · nonDerivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,396 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| November 13, 2023 Filed Nov 13, 2023 21:14 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 138 | $22.98 | $3,171.24 |
DisclosureSEC source: 0001576427-23-000135 · wk-form4_1699910026.xml · nonDerivative · entry 2 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,771 F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 21:14 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 5,833 | $23.39 | $136,433.87 |
DisclosureSEC source: 0001576427-23-000135 · wk-form4_1699910026.xml · nonDerivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,633 F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 20:08 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 6,095 | $0.00 Strike: $18.71 | $0.00 |
DisclosureSEC source: 0001576427-23-000083 · wf-form4_168616850077547.xml · derivative · entry 3 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,302 Underlying: Ordinary Shares · 6,095 shares Expires 2029-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.71 using the exchange rate as of June 5, 2023 (1.00 = $ 1.073). F5 · derivative.exercise_date: Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 20:08 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 6,095 | $33.50 | $204,182.50 |
DisclosureSEC source: 0001576427-23-000083 · wf-form4_168616850077547.xml · nonDerivative · entry 2 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,800 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.44 to $33.685 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 20:08 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 6,095 | $18.71 | $114,037.45 |
DisclosureSEC source: 0001576427-23-000083 · wf-form4_168616850077547.xml · nonDerivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.71 using the exchange rate as of June 5, 2023 (1.00 = $ 1.073). F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 4,846 | $0.00 Strike: $18.62 | $0.00 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · derivative · entry 12 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,397 Underlying: Ordinary Shares · 4,846 shares Expires 2029-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.62 using the exchange rate as of March 7, 2023 (1.00 = $ 0.9366). F10 · derivative.exercise_date: Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 4,846 | $32.03 | $155,193.15 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 8 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F8 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 4,846 | $18.62 | $90,232.52 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 7 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.62 using the exchange rate as of March 7, 2023 (1.00 = $ 0.9366). F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 12,177 | $0.00 Strike: $18.49 | $0.00 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · derivative · entry 11 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,243 Underlying: Ordinary Shares · 12,177 shares Expires 2029-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.49 using the exchange rate as of March 6, 2023 (1.00 = $ 0.9431). F10 · derivative.exercise_date: Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 22,400 | $0.00 Strike: $20.90 | $0.00 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · derivative · entry 10 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 22,400 shares Expires 2028-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431). F9 · derivative.exercise_date: Warrant granted on October 25, 2018. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 25, 2028. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 2,600 | $0.00 Strike: $20.90 | $0.00 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · derivative · entry 9 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,400 Underlying: Ordinary Shares · 2,600 shares Expires 2028-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431). F9 · derivative.exercise_date: Warrant granted on October 25, 2018. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 25, 2028. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 12,177 | $32.36 | $393,986.84 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 6 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $ 32.845 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 12,177 | $18.49 | $225,152.73 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 5 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.49 using the exchange rate as of March 6, 2023 (1.00 = $ 0.9431). F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 22,400 | $32.36 | $724,752.00 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 4 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $ 32.845 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 22,400 | $20.90 | $468,160.00 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 3 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431). F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 2,600 | $32.67 | $84,952.40 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 2 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.51 to $32.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:17 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 2,600 | $20.90 | $54,340.00 |
DisclosureSEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431). F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 21:02 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 5,760 | $26.06 | $150,105.60 |
DisclosureSEC source: 0001576427-22-000108 · wf-form4_166923733095418.xml · nonDerivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:03 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 3,640 | $41.34 | $150,477.60 |
DisclosureSEC source: 0001576427-21-000076 · wf-form4_163968859781310.xml · nonDerivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,040 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 21:02 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 8,400 | $19.10 | $160,444.20 |
DisclosureSEC source: 0001576427-20-000103 · wf-form4_160651093828936.xml · nonDerivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,400 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| October 24, 2019 Filed Oct 28, 2019 20:03 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 26,420 | $7.57 Strike: $19.41 | $199,999.40 |
DisclosureSEC source: 0001576427-19-000091 · wf-form4_157229289633828.xml · derivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,420 Underlying: Ordinary Shares · 26,420 shares Expires 2029-10-23 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 17.44 Euros. The U.S. dollar equivalent of the exercise price is $19.41 using the European Central Bank rate as of October 22, 2019 (1.00 = $1.1130), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants. F4 · price: The subscription price of the non-employee warrant is $7.57. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on October 24, 2020 and an additional 1/16th of the grant will vest quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 21:16 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 25,000 | $7.87 Strike: $22.45 | $196,750.00 |
DisclosureSEC source: 0001576427-18-000089 · wf-form4_154214375665713.xml · derivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2028-10-25 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 19.71 Euros. The U.S. dollar equivalent of the exercise price is $22.45 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants. F4 · price: The subscription price of the non-employee warrant is $7.87. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on October 25, 2019 and an additional 1/16th of the grant will vest quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 27, 2017 Filed Jul 27, 2017 20:14 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 3,915 | $0.00 Strike: $51.66 | $0.00 |
DisclosureSEC source: 0001576427-17-000147 · wf-form4_150118643089302.xml · derivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,915 Underlying: Ordinary Shares · 3,915 shares Expires 2027-07-27 F1 · derivative.exercise_price: The exercise price of the warrant is 44.37 euros. The U.S. dollar equivalent of the exercise price is $51.66 using the European Central Bank (Close of Business) rate for July 26, 2017 (1.00 = $1.1644). F2 · derivative.exercise_date: Warrant granted on July 27, 2017. One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.